). When we stratified distance from the hilum by lesion size, the difference in yield was not significant. However, lesions < 2 cm had a diagnostic yield of 14% (2 of 14) when located in the peripheral third vs 31% (5 of 16) when located in the inner two thirds of the lung. There was a trend toward higher combined diagnostic yield in right middle and lingular lobes when compared to all other segments (p ‫؍‬ 0.09, 2 ). Transbronchial biopsy, washing, and brushing were complementary in improving the yield of bronchoscopy. Conclusions: Size is the strongest determinant of diagnostic yield in bronchoscopy when evaluating SPNs. The yield of bronchoscopy is particularly low in lesions < 2 cm that are located in the outer third of the lung. Thus, alternative diagnostic approaches may be preferable in this situation.
B
ronchoscopy has been used for 30 years in evaluation of solitary pulmonary nodules (SPNs) and peripheral lung masses. 1 However few studies have addressed the yield of flexible fiberoptic bronchoscopy (FFB) in SPNs (Table 1) . [2] [3] [4] [5] [6] [7] In some studies, 2, 3 SPNs were not well defined, and others 2,4,5 did not exclude patients who had endobronchial lesions on bronchoscopy. Previous published studies 4,6 -14 on SPNs and peripheral lung masses have consistently shown that lesion size influences the diagnostic accuracy of bronchoscopy. However, it is still controversial whether lesion location relative to the hilum influences yield. 8 -10,13 Additionally, some studies 9, 11, 15 have shown that bronchial washing (BW) provides no added benefit to the diagnostic yield in patients undergoing bronchial brushing (BB) and transbronchial biopsy (TBB). In this large series, we sought to systematically analyze the factors that determine the diagnostic yield of FFB in the evaluation of SPNs.
Materials and Methods
We retrospectively reviewed the medical records of all patients who underwent bronchoscopy at the Houston Veterans Affairs Medical Center (HVAMC) between January 1992 and August 1996. One hundred seventy-seven patients met the following criteria for inclusion in the study: (1) presence of a single circumscribed lung mass completely surrounded by aerated lung without associated abnormalities (including atelectasis, pneumonitis, satellite lesions, or cavity); (2) lesions that were not visible endoscopically (no endobronchial lesions or extrinsic compression); (3) availability of standard chest radiographs (posteroanterior and lateral) and CT scans; (4) availability of fluoroscopicallyguided brushings, washings, and TBBs; and (5) a final pathologic diagnosis from either the bronchoscopy procedure, thoracotomy and excisional biopsy, transthoracic or transbronchial needle aspiration (TBNA) biopsy, or from biopsy of metastases. Two patients were included in whom a definitive diagnosis was not reached, but the chest radiograph had remained stable for 2 years following their bronchoscopy. Patients known to have lung metastasis from an extrapulmonary source were excluded from the study.
All bronchoscopy procedures were performed by pulmonary fellows at the HVAMC under pulmonary faculty supervision (26 fellows and 8 attending physicians). A variety of fiberoptic bronchoscopes (models BF P20D, BF IT10, and BF IT30; Olympus; Tokyo, Japan) along with brushes and biopsy forceps supplied with them were used. All procedures were performed via the transnasal route under local anesthesia and sedation. After complete inspection of the bronchial tree, including the subsegmental bronchi, the mass was visualized using C-arm fluoroscope in multiple planes, and multiple brushings, washings, and TBBs were performed. All the biopsy specimens were reviewed by pathology staff at the HVAMC. A histologic diagnosis of nonspecific fibrosis was considered nondiagnostic. A diagnosis of acute inflammation was considered nondiagnostic unless the final surgical pathology came back as pneumonia, or the lesion disappeared after a course of antibiotic.
The radiographic appearance of the lesions was analyzed retrospectively by two of the authors (WB, MR). We measured the three diameters of every lesion on two chest radiograph views (posteroanterior and lateral: cephalad-caudad, ventral-dorsal, medial-lateral) and the CT scan (ventral-dorsal, medial-lateral). For stratification purposes, the greatest diameter among the three images was considered to be the actual size of the lesion. We also determined the segmental location of the lesions. If the segment could not be determined from the radiographs, the segment from which sampling was done at the time of bronchoscopy was considered to be the actual site of the lesion. We divided the area around the hilum on CT scans into three elliptical regions: lesions located within the inner third ellipse were called central, lesions located within the middle third ellipse were called intermediate, and lesions located within the outer third ellipse were called peripheral. When a nodule overlapped two contiguous elliptical regions, it was assigned to the ellipse that contained greater than half the area of the nodule. Finally, we determined if the CT scan cuts contained the bronchus sign 3, 5, 16, 17 (the finding on CT scan of a bronchus leading directly to or contained within the nodule or mass).
Results
One hundred seventy-seven patients fulfilled the inclusion criteria and were enrolled in the study. They were all men (mean age, 65 Ϯ 8 years; range, 41 to 83 years), and were all active or ex-smokers (mean, 59 Ϯ 23 pack-years; range, 24 to 126 packyears).
One hundred fifty-one lesions were malignant (80 adenocarcinoma, 58 squamous cell carcinoma, 3 undifferentiated nonsmall cell carcinomas, 6 smallcell carcinomas, and 4 carcinoid tumors). Twenty-six lesions were benign (12 noncaseating granuloma, 6 caseating granuloma, 1 hamartoma, 1 Dirofilaria immitis, 4 organizing pneumonias, and two patients whose nodule remained unchanged on chest radiograph for 2 years following bronchoscopy).
In 71 patients, bronchoscopy was nondiagnostic. In 42 of these patients, diagnosis was established following thoracotomy. In 22 patients, we established the diagnosis by either transthoracic fineneedle aspiration (n ϭ 18), or by TBNA (n ϭ 4). In four patients, biopsy of a metastatic lesion was successful. One patient with a nondiagnostic bronchoscopy had a subsequent sputum cytology positive for carcinoma. In two patients with nondiagnostic bronchoscopies, the appearance of the lesion on chest radiograph remained stable for 2 years, and these lesions were designated as benign.
The yield of bronchoscopy in all lesions was 60% (106 of 177). The diagnostic yield of bronchoscopy in malignant and benign lesions was 64% (97 of 151) and 35% (9 of 26) respectively (p ϭ 0.005, 2 ; Table  2 ). As shown in Table 2 , the yield of bronchoscopy in SPN was directly related to the size of the lesion (p Ͻ 0.001, 2 ). Table 3 ). To neutralize the effect of size on yield of bronchoscopy, we stratified the lesions by distance from the hilum within each of the four size categories. The diagnostic yield of bronchoscopy was 14% (2 of 14) when lesions were Յ 2 cm and peripherally located, as compared to 31% (5 of 16) when lesions were Ͼ 2 cm and intermediately located (p ϭ 0.3, Fisher's Exact test; Table 4 ). There were no central lesions Յ 2 cm; the two positive lesions that were peripheral and Յ 2 cm were both tuberculosis (one had positive BW culture, and the other had positive TBB).
When we analyzed the lesions by bronchopulmonary segment, we found a very high incidence of lung cancer in the right upper lobe (RUL) of the lung. The RUL alone accounted for 46% (70 of 151) of lung cancers in our series (Table 5 ). There was a trend toward higher combined bronchoscopy yield when lesions were located in the right middle lobe (RML) or the lingular segment (78%, 14 of 18) as compared to all other lobes (58%, 92 of 159; p ϭ 0.09, 2 ). TBB, BB, and BW were complementary in improving the yield of bronchoscopy. The diagnostic yield from TBB was 52% (91 of 176), the yield from BB was 41% (73 of 177), and the yield from BW was 40% (71 of 177; Table 6 ). TBB was the only diagnostic modality positive in 5 benign and 16 malignant lesions. BB was the only modality positive in four malignant lesions. BW was the only modality positive in three benign (all tuberculosis) and four malignant lesions.
Three lesions that were Ͼ 4 cm had a positive bronchus sign on CT scan, and in all three cases, bronchoscopy was positive for malignancy.
Discussion
Although multiple studies have investigated factors affecting diagnostic yield in FFB, only seven English-language studies have addressed SPNs (Table 1). Diagnostic yields in SPN studies ranged from 18 to 62%. In the study by Torrington and Kern, 2 SPNs were poorly characterized and were defined only as meeting criteria for stage I carcinomas (T1N0M0 or T2N0M0). Thus, there was no upper limit for the size of lesions, and it is uncertain whether lesions that were pleural based or had associated atelectasis were included (as these would be consistent with a T2 designation). Five patients with bronchogenic carcinoma had endobronchial lesions, and biopsies were positive in four of the five. We also note that in five patients in the Wallace and Deutsch series, 4 endobronchial lesions were found, and, presumably, biopsies were performed, affecting the calculated yield. This is also true in the series presented by Gaeta and others, 5 where 3 of 26 patients had visible endobronchial lesions that were sampled for diagnostic examination. Naidich and colleagues 3 never defined a SPN. Our definition of SPN is identical with that used by Wallace and Deutsch, 4 except that we included lesions Ͼ 4 cm in diameter. In Table 1 , we show the calculated diagnostic yields for our own study, and for the studies of Fletcher and Levin 6 and Lai and colleagues, 7 after excluding lesions Ͼ 4 cm in diameter. The very high positive yield for benign lesions in the study by Lai and colleagues 7 is influenced by the frequency with which a positive culture for tuberculosis was obtained from BW (15 of 40; 38%). Forty of 170 patients (24%) in their series had tuberculosis (as compared to 3% in the current study).
In this study, we found that yield of bronchoscopy in malignant lesions is much greater than in benign lesions. The most important determinant of diagnostic accuracy is the lesion size, and location of the lesion peripheral to the hilum is an important factor in influencing yield when lesions are Յ 2 cm. Additionally, there is a trend toward higher combined yield in lesions located in the right middle and lingular lobes. All three diagnostic modalities are complementary in improving the yield of bronchoscopy.
The lower diagnostic yield in benign compared to malignant lesions may be due to the nature of these lesions, as well as to the fact that a large proportion of benign lesions in our series were Յ 2 cm in size (54%; 14 of 26), as compared to malignant lesions, where only 11% (16 of 151) were Յ 2 cm in size (p Ͻ 0.001, 2 ). The effect of lesion size on yield has been demonstrated in our own and prior studies. 4,6 -14 However, the effect of location on yield has been inconclusive. 8 -10,13 Lesion position can be defined by lobar or segmental location, or by position relative to some reference point, such as distance from the hilum. Radke and colleagues 10 found that when lesions were Ն 2 cm in size, the location of the lesions had no further independent effect on the yield of bronchoscopy. Cortese and McDougall 9 obtained their best results when lesions were Ͼ 5 cm from the hilum (67% positive yield). Moreover, none of the four lesions that were Ͻ 1.5 cm from the hilum were diagnosed. Stringfield and associates 8 found the best diagnostic yield was obtained when lesions were Ͼ 2 cm in size and located within 2 to 6 cm from the hilum (71%; 10 of 14); only one in four of the lesions located Ͼ 6 cm from the hilum was diagnosed. In our series, we defined the location of our SPNs based on the CT scan, rather than the chest radiograph, because this better estimated the distance from the central airways. We found a very low diagnostic yield in lesions Յ 2 cm and located in the outer third of the lung, when compared to lesions Յ 2 cm and located in the middle third (2 of 14, 14% vs 5 of 16, 31%; p ϭ 0.30, Fisher's Exact Test). Even though the difference in diagnostic yield did not reach statistical significance, we believe that, based on our own and prior observations, the odds of obtaining a positive yield in peripheral lesions that are Ͻ 2 cm in size is very low. Thus, routine bronchoscopy of peripheral lesions that are Ͻ 2 cm and peripheral is not always justifiable. Cases should be individualized based on accessibility of a lesion to transthoracic fine-needle aspiration, risks of malignancy, and patients' tolerance of thoracotomy.
Chechani 12 found a lower combined diagnostic yield in basal segments of the lower lobes and the apical segment of the upper lobes as compared to all other segments (58% vs 83%; p ϭ 0.05). In his series, all patients underwent TBNA in addition to TBB, BB, and BW. In the present study, we did not find any significant difference between these two bronchopulmonary segment groups (29 of 49, 59% vs 77 of 128, 60%). We did find, however, a trend toward increase in combined diagnostic yield in RML and lingular segments as compared to all other segments (p ϭ 0.09, 2 ). The reason for this finding might be a more direct accessibility of biopsy forceps to these particular segments.
Several authors 3, 5, 16 have advocated the use of high-resolution CT (HRCT) scans to predict the value of bronchoscopy in diagnosing peripheral lung lesions. The finding of a bronchus transiting the lesion (bronchus sign) suggests accessibility by FFB. HRCT is also useful in delineating the calcification of SPNs that routine chest radiography or CT scanning (8-to 10-mm sections) might miss. 16 In our series, using regular CT, we found only three cases with a positive bronchus sign. Naidich and colleagues 3 first described the bronchus sign in SPN. In their study, they obtained a positive bronchoscopic diagnosis in 60% of lesions with this sign. This is no different from our yield in an unselected series (60%). All 14 central lesions (the inner one third of the lung by CT scan) in their series had a positive bronchus sign, 10 of which (71%) had positive bronchoscopy. Of 51 peripheral lesions (corresponding to our intermediate and peripheral categories), 20 had a positive bronchus sign (39%). A positive bronchoscopic diagnosis was obtained in 11 of these 20 patients (55%). Again, this is not significantly different from our yield in an unselected series (88 of 155; 57%). In the series presented by Gaeta and others, 5 no TBB was positive in lesions beyond the fifth-order bronchi, even when a positive CT bronchus sign was noted (2 of 16 patients). Eight out 10 lesions with third-to fifth-order positive CT bronchus sign had a positive TBB biopsy at bronchoscopy. We can conclude from these data that central lesions are more likely to have positive bronchoscopy, and peripheral lesions are less likely to have positive bronchoscopy. Thus, we find it difficult to justify the additional expense of a HRCT in selecting patients with SPN for bronchoscopy. Routine CT scan is sufficient to provide information regarding the location of nodule relative to the hilum, the presence or absence of enlarged mediastinal lymph nodes, and the assurance that we are dealing with SPN, rather than multinodular disease.
It has been debated whether the additional yield of BW justifies its cost. In the series of Cortese and McDougall, 9 BW did not add to the yield of bronchoscopy; TBB and BB were complementary. In addition, Fletcher and Levin 11 found that BW was positive in only 2 out of 54 bronchoscopies (4%), but TBB was also positive in both of these cases. Gracia and associates 17 conducted a prospective study to determine the value of BW in a series of 35 peripheral lung cancer patients undergoing bronchoscopy without use of fluoroscopy. BW was positive in 7 of 35 cases (20%), and it was the only diagnostic modality positive in only 1 case. Our series has the highest positive yield with BW to date. We obtained a positive BW in 71 of 177 of cases (40%). In seven patients, the diagnosis would have been missed if these specimens had not been collected and reviewed. BW entails minimal effort, time, and cost during routine bronchoscopy. Given the frequency with which TBB is positive, we believe that protocols should be developed in which BB and BW are acquired, minimally processed, and then held until it is known whether the TBB is diagnostic. The availability of these samples for further processing and interpretation when the TBB is negative might obviate the need for an additional procedure, involving both cost and risk to the patient.
In conclusion, we have found that lesion size is the strongest determinant of the yield of FFB in SPN or a discrete lung mass. The yield of FFB is particularly low in lesions Յ 2 cm that are located in the outer third of the lung. Thus, other diagnostic approaches may be preferable in this situation. We also found that BW seems to be a valuable diagnostic tool in improving the yield of bronchoscopy.
